forecast glp-1 prescriptions growth 2025 semaglutide tirzepatide Weight Loss Drug Market Size, Share GLP-1 Market Size, Share |

M.KufarevaI.StrathearnK

Liposomal incorporation of Lavandin essential oil by a thin-film hydration method and by particles from gas-saturated solutions

Nat Rev Neurol 20 , 232244 (2024)

Topiramate is not a P-glycoprotein substrate

The maximum dose of Zepbound for weight loss and weight management is 15 mg once per week

The Board of Pharmacy has published new requirements for nonresident pharmacies taking effect July 1, 2026, requiring each nonresident pharmacy to identify a California-licensed pharmacist employed and working at that pharmacy to serve as pharmacist-in-charge over its California operations, fully authorized to ensure operational compliance with California law and trained by the Board